Skip to content

A Pilot Study to Evaluate BeCurie Device in Poor Sleep Quality.

A Pilot Multicentric Clinical Trial to Evaluate the Impact of BeCurie Device on the Individuals with Poor Sleep Quality.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/051108
Enrollment
40
Registered
2023-03-28
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G470- Insomnia

Interventions

Intervention1: BECURIE Device: BeCurie is a mental wellbeing device. Which is programmed to generate variable magnetic fields. That supports or improves the quality of sleep in Individuals with poor s

Sponsors

Aether Mindtech Solutions Pvt Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with poor quality of sleep (like difficulty in falling asleep, multiple awakening after falling asleep) for not more than 3 months. Subjects aged from 18 years to maximum of 70 years. Subjects willing to sign an ICF.

Exclusion criteria

Exclusion criteria: Having a significant health or psychiatric conditions/ disease that in the opinion of the investigator hinders active participation in the study. Severe Sleep Disorder or Severe Insomnia. Individuals with moderate to severe insomnia under medication. Subjects on antipsychotics or other medications that may cause insomnia. Having history of chronic drug or alcohol abuse. Skin related disorders like skin allergies or contact dermatitis. Pregnant women or lactating women. Contraindications to the device under investigation (skin irritability or allergy to electrode glue implanted devices as pacemakers or defibrillators. Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the subject. A history of a serious medical condition such as cancers. History of allergy or hypersensitivity to any medical device or its components. Subjects enrolled in other clinical study.

Design outcomes

Primary

MeasureTime frame
Change in quality of sleep.Timepoint: On Day 15 as compared to baseline (Day 0) will be measured by the following based on a simple questionnaire.

Secondary

MeasureTime frame
ActigraphyTimepoint: Actigraphy is a wearable wrist band like watch. It is used to check the sleep reports. Actigraphy parameters Such as Sleep monitoring: Deep sleep, light sleep, rapid eye movement (REM), Sleep efficiency, Nocturnal wake time, Total nocturnal sleep time and the number of nocturnal awakenings. The data is captured at Day 1, Day 8 and Day 15â??th visit. Comparison from base line to the end of the study (Day 1 to Day 15).

Countries

India

Contacts

Public ContactPV Shyam Sunder

Renova Neelima Hospitals

dr.kspandana92@gmail.com9440141524

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026